Low-Dose Adjuvant Aspirin Decreases Incidence of Recurrence Among Patients with Resected PI3K-Altered CRC By Ogkologos - September 30, 2025 213 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ALASCCA study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Lurbinectedin Zongertinib Shows Durable Antitumour Activity in First-Line Treatment for Patients with Previously Untreated HER2-mutated Advanced NSCLC Patient Guide on Immunotherapy Side Effects and Their Management Now Available Also in the Ukrainian MOST POPULAR FDA Grants Accelerated Approval to Amivantamab-vmjw for Metastatic NSCLC with EGFR... May 28, 2021 FDA Approves Osimertinib with Platinum-Based Chemotherapy for EGFR-mutated Locally Advanced or... February 23, 2024 The Nobel Prize winner helping us treat children’s cancers November 8, 2022 Ending smoking could more than halve England’s cancer inequality gap September 21, 2022 Load more HOT NEWS Shannen Doherty Opens Up About Life After Cancer And BH90210 Treating the Whole Person: How Cancer Centers Are Addressing Social Needs How Adolescent and Young Adult Cancer Survivors Can Cope With the... EMA Recommends Granting a Marketing Authorisation for Toripalimab
